The Nonsteroidal FXR Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With PSC
Hepatology - United States
doi 10.1002/hep.30509
Full Text
Open PDFAbstract
Available in full text
Date
March 10, 2019
Authors
Publisher
Wiley